Latest filing published 24 Feb 2014 for Traws Pharma, Inc., €420k.
Insider track record
No signal scores available.
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -62.0%Entry US$356,625.00 · Close at T+365 US$135,562.50
- -73.1%Entry US$478,125.00 · Close at T+365 US$128,812.50
- -71.3%Entry US$645,750.00 · Close at T+365 US$185,062.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
& Jane Hoffman 2013 Descendants Michael: trading record in brief
& Jane Hoffman 2013 Descendants Michael discloses dealings in Traws Pharma, Inc. to SEC (Form 4). Between 30 July 2013 and 21 February 2014, the trades on record add up to 20 filings.
The open-market record is one-sided, with 12 purchases worth €13.0M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2014, the count stands at 4 purchases and no sales.
The median purchase comes to €61k. After 6 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -42.9%. These figures describe past trades and do not predict future prices.
Most recently, on 24 February 2014, the filings show an open-market purchase worth €420k in Traws Pharma, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to & Jane Hoffman 2013 Descendants Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 71,740 shares@ US$8.03Common StockSEC:0001179110-14-003410:0Canonical exit: 21 May 2014 (T+90)
- 71,740 shares@ US$8.91Common StockSEC:0001179110-14-003410:1Canonical exit: 22 May 2014 (T+90)
- 31,706 shares@ US$11.96Common StockSEC:0001179110-14-001425:0Canonical exit: 24 Apr 2014 (T+90)
- 25,589 shares@ US$11.86Common StockSEC:0001179110-14-001425:1Canonical exit: 27 Apr 2014 (T+90)
- 100 shares@ US$14.37Common StockSEC:0001179110-13-017005:0Canonical exit: 20 Feb 2014 (T+90)
- 4,900 shares@ US$14.39Common StockSEC:0001179110-13-017005:1Canonical exit: 20 Feb 2014 (T+90)
- 5,000 shares@ US$11.95Common StockSEC:0001179110-13-016722:0Canonical exit: 13 Feb 2014 (T+90)
- 5,000 shares@ US$11.99Common StockSEC:0001179110-13-016722:1Canonical exit: 13 Feb 2014 (T+90)
- 1,900 shares@ US$12.21Common StockSEC:0001179110-13-016722:2Canonical exit: 13 Feb 2014 (T+90)
- 7,800 shares@ US$11.97Common StockSEC:0001179110-13-016722:3Canonical exit: 13 Feb 2014 (T+90)
- 476,087 sharesCommon StockSEC:0001179110-13-012441:3
- 85,744 sharesCommon StockSEC:0001179110-13-012441:4
- 172,411 sharesCommon StockSEC:0001179110-13-012441:5
- 226,024 sharesCommon StockSEC:0001179110-13-012441:6
- 1,226,942 sharesCommon StockSEC:0001179110-13-012441:7
- 266,712 sharesCommon StockSEC:0001179110-13-012441:2
- 83,857 sharesCommon StockSEC:0001179110-13-012441:0
- 105,363 sharesCommon StockSEC:0001179110-13-012441:1
- 1,000,000 shares@ US$15.00Common StockSEC:0001179110-13-012441:8Canonical exit: 28 Oct 2013 (T+90)
19 of 19 declarations